Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT - Archive ouverte HAL
Article Dans Une Revue European Radiology Année : 2020

Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT

Domaines

Statistiques [math.ST] Méthodologie [stat.ME] Applications [stat.AP] Machine Learning [stat.ML]

Arthur Tenenhaus  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-03111135

Soumis le : vendredi 15 janvier 2021-10:12:12

Dernière modification le : mardi 16 juillet 2024-11:56:03

Fichier non déposé

Dates et versions

hal-03111135 , version 1 (15-01-2021)

Identifiants

Citer

Sébastien Mulé, Julia Chalaye, François Legou, Arthur Tenenhaus, Julien Caldéraro, et al.. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. European Radiology, 2020, 30 (10), pp.5348-5357. ⟨10.1007/s00330-020-06923-5⟩. ⟨hal-03111135⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS SUP_LSS SUP_SIGNAUX UPEC CENTRALESUPELEC UNIV-PARIS-SACLAY GS-ENGINEERING GS-COMPUTER-SCIENCE GS-SPORT-HUMAN-MOVEMENT HUB-IA
18 Consultations
0 Téléchargements

Altmetric

Partager

More